New Zealand's Neuren Pharmaceuticals is collaborating with the US Army's Walter Reed Institute of Research, to develop neuroprotective compounds for treatment of traumatic brain injury.
Brain Books
Organizations
Neuro Stocks
« Gene Chips Watch Neuronal Stem Cells Change | Main | Imaging May Mark Onset of Schizophrenia »
Comments
Verify your Comment
Previewing your Comment
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Recent Posts
- Results Bolster Tysabri for Multiple Sclerosis
- Walking Robot Goes on Sale in Japan
- Diffusion MRI Can Track Brain Tumor Treatments
- A Rare Buff of Smoke Threatens Stroke
- Luckiest Man: The Life and Death of Lou Gehrig [BOOK RECOMMENDATION]
- 75% Lose Sleep
- 80 Multiple Sclerosis Genes Identified
- Harvard Bedamned: Brains do Differ in Boys and Girls
- Imaging May Mark Onset of Schizophrenia
- Company: Neuren Pharmaceuticals Seeks to Protect Damaged Neurons
I have learned about this at school today!
Posted by: emme | March 29, 2005 at 09:31 PM